FORMULATION AND EVALUATION OF S-(-)-AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE TABLETS
The objective of the present study was to develop a tablet formulation of S-(-)- amlodipine besylate chiral separation drug and nebivolol hydrochloride for better management of hypertension, while reducing or avoiding undesirable adverse effects, which are often associated with administration of a r...
Main Authors: | Shaikh S.A, Shaikh S.S, Shahi S.R., Shookur M.A., Reddy L.K, Padalkar A.N, Thube Mahesh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2010-06-01
|
Series: | Journal of Advanced Pharmaceutical Technology & Research |
Subjects: | |
Online Access: | http://www.japtr.org/Manuscripts/Formulation%20and%20Evaluation%20of%20S-(-)-Amlodipine%20Besylate%20and%20Nebivolol%20Hydrochloride%20Tablets.pdf |
Similar Items
-
Formulation and evaluation of S-(-)-Amlodipine besylate and nebivolol hydrochloride tablets
by: S A Shaikh, et al.
Published: (2010-01-01) -
Physicochemical equivalence studies of two amlodipine tablet formulations
by: Kecman Sanja, et al.
Published: (2018-01-01) -
Inclusion complexes of amlodipine besylate and cyclodextrins
by: Kapor Agneš, et al.
Published: (2010-08-01) -
Validated stability-indicating HPLC-DAD method of analysis for the antihypertensive triple mixture of amlodipine besylate, valsartan and hydrochlorothiazide in their tablets
by: Rasha A. Shaalan, et al.
Published: (2017-02-01) -
Development of Colorimetric Method for the Quantitative Analysis of Amlodipine Besylate in Dosage form Using 4-Dimethyleaminobenzaldehyde as Derivatizing Reagent
by: Abdul Ghani Memon, et al.
Published: (2020-06-01)